Screener
ClearPoint Neuro CLPT Operating Cash Flow
Operating Cash Flow at other companies
Other financials
Where this comes from
Reported directly by ClearPoint Neuro in its filing.
Tagged under the XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities.
The source filing: ClearPoint Neuro’s 10-Q, filed May 13, 2026.
- Filed
- May 13, 2026, 5:00 PM EDT
- Fiscal quarter
- Q1 FY2026
- Calendar quarter
- Q1 2026
- Accession
- 0001193125-26-221890
| Line item | Three Months Ended March 31, 2026 | Three Months Ended March 31, 2025 |
|---|---|---|
| Accounts payable and accrued expenses | (437) | (2,882) |
| Lease liabilities | (391) | (234) |
| Contract liabilities | 172 | (581) |
| Net cash flows from operating activities | (7,967) | (6,172) |
| Cash flows from investing activities: | ||
| Purchases of property and equipment | (645) | (183) |
| Net cash flows from investing activities | (645) | (183) |
| Cash flows from financing activities: |
ITEM 1. FINANCIAL STATEMENTS
FAQ
- What is ClearPoint Neuro's operating cash flow?
- ClearPoint Neuro (CLPT) reported operating cash flow of -$7.97M in Q1 2026.
- How has ClearPoint Neuro's operating cash flow changed year-over-year?
- ClearPoint Neuro's operating cash flow decreased by 29.1% year-over-year, from -$6.17M to -$7.97M.
- What is the long-term trend for ClearPoint Neuro's operating cash flow?
- Over 4 years (2021 to 2025), ClearPoint Neuro's operating cash flow has grown at a 17.1% compound annual growth rate (CAGR), from -$12.7M to -$23.9M.
- What does operating cash flow mean?
- Total cash generated by or used in core business operations — the single most important cash flow metric for assessing business health.
Ask your AI about ClearPoint Neuro's operating cash flow.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude